ArticleFrontiers in pharmacology2026

Anjiang formula inhibits PVN microglial activation and lowers blood pressure by targeting RhoA/ROCK2 pathway: a retrospective clinical and experimental study.

Xuanjing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.